drospirenone and ethinyl estradiol combination has been researched along with desloratadine in 1 studies
| Studies (drospirenone and ethinyl estradiol combination) | Trials (drospirenone and ethinyl estradiol combination) | Recent Studies (post-2010) (drospirenone and ethinyl estradiol combination) | Studies (desloratadine) | Trials (desloratadine) | Recent Studies (post-2010) (desloratadine) |
|---|---|---|---|---|---|
| 130 | 51 | 102 | 465 | 146 | 166 |
| Protein | Taxonomy | drospirenone and ethinyl estradiol combination (IC50) | desloratadine (IC50) |
|---|---|---|---|
| 5-hydroxytryptamine receptor 4 | Cavia porcellus (domestic guinea pig) | 0.03 | |
| Aldo-keto reductase family 1 member B1 | Rattus norvegicus (Norway rat) | 1.116 | |
| Muscarinic acetylcholine receptor M2 | Homo sapiens (human) | 0.107 | |
| Muscarinic acetylcholine receptor M4 | Homo sapiens (human) | 0.339 | |
| Muscarinic acetylcholine receptor M5 | Homo sapiens (human) | 0.292 | |
| Muscarinic acetylcholine receptor M1 | Homo sapiens (human) | 0.267 | |
| Alpha-2B adrenergic receptor | Homo sapiens (human) | 2.146 | |
| Muscarinic acetylcholine receptor M3 | Homo sapiens (human) | 0.446 | |
| Sodium-dependent noradrenaline transporter | Homo sapiens (human) | 1.116 | |
| Histamine H2 receptor | Homo sapiens (human) | 1.099 | |
| 5-hydroxytryptamine receptor 2A | Homo sapiens (human) | 0.033 | |
| 5-hydroxytryptamine receptor 2C | Homo sapiens (human) | 0.03 | |
| Sodium-dependent serotonin transporter | Homo sapiens (human) | 0.23 | |
| Histamine H1 receptor | Homo sapiens (human) | 0.0059 | |
| D(3) dopamine receptor | Homo sapiens (human) | 1.906 | |
| 5-hydroxytryptamine receptor 2B | Homo sapiens (human) | 0.043 | |
| 5-hydroxytryptamine receptor 6 | Homo sapiens (human) | 2.171 | |
| Sodium-dependent dopamine transporter | Homo sapiens (human) | 3.879 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bourke, J; Roper, S | 1 |
1 other study(ies) available for drospirenone and ethinyl estradiol combination and desloratadine
| Article | Year |
|---|---|
In with the new: the determinants of prescribing innovation by general practitioners in Ireland.
Topics: Age Factors; Androstenes; Citalopram; Drug Prescriptions; Drug Utilization; Ethinyl Estradiol; General Practitioners; Humans; Information Dissemination; Insurance Claim Review; Ireland; Lactones; Loratadine; Nicotine; Omeprazole; Practice Patterns, Physicians'; Residence Characteristics; Sulfones; Therapies, Investigational; Time Factors | 2012 |